Staph Leavenworth Bakali (Chairman)
Dr. Mustapha (“Staph”) Leavenworth Bakali holds a First Class Honours Degree from City of London Polytechnic and an M. Sc. (With Distinction) from London Business School. He is President and Chief Operating Officer of the Clinton Health Access Initiative (CHAI).
Staph has close to 30 years of experience in building and managing large and early stage operations in the Life Sciences sector.
When he was Worldwide Head of Sales and Marketing of Chiron Corporation’s Vaccines Division, his negotiations resulted in the development of a low-cost combination pentavalent vaccine to serve children in the world’s poorest countries.
Staph cofounded LeapFrog Investments, the world’s first and largest investor in companies that insure underserved people in Africa and Asia.
He serves on numerous boards as an advisor and as a non-executive director.
